Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Badushengjisan for diabetic foot ulceration
ChiCTR2100052646Phase 4Recruiting
- Sponsor
- Liyuan Hospital
- Start
- Dec 2021
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of badushengjisan in diabetic foot ulcer (DFU) (2 arms), sponsored by Liyuan Hospital. Primary endpoint: Total effective rate. Started Dec 2021; status: recruiting.
02
Drugs
badushengjisan
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ChiCTR2100052646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052646.